Updated Requirements for Clinical Trial Authorization Applications in the UAE

Summary

The UAE Department of Health has issued comprehensive updates to clinical trial authorization requirements effective immediately. Key changes include mandatory electronic submission of all CTA documents, enhanced informed consent requirements with Arabic language provisions, new principal investigator qualification criteria, and updated facility inspection standards. Sponsors must transition to the new eCTD format within 90 days.